LY-2584702 hydrochloride is primarily investigated for its potential therapeutic applications in cancer treatment. It functions as an inhibitor of specific signaling pathways that are often dysregulated in various types of cancer. By targeting these pathways, it aims to inhibit tumor growth and proliferation. Research has focused on its efficacy in preclinical models, particularly in cancers where the targeted pathways play a critical role. Additionally, it has been studied in combination with other anticancer agents to enhance therapeutic outcomes. Its application is still largely experimental, with ongoing studies to determine its safety, efficacy, and optimal dosing in clinical settings.